Sales

The latest news from the healthcare marketing and communications sector involving pharmaceutical, biotech and medical device companies.

Novartis asks FDA for Galvus review extension
Novartis asks FDA for Galvus review extension
November 15, 2006
12:13 am

Novartis has asked the FDA to extend the review period for its highly anticipated developmental diabetes drug Galvus by three months to allow the agency to examine new clinical trials data.

Genentech acquires Xolair partner Tanox
Genentech acquires Xolair partner Tanox
November 10, 2006
7:00 pm

Genentech has agreed to acquire its Xolair co-marketer, the Houston-based biotech firm Tanox, in a deal worth $919 million.

3M sheds pharma unit for $2.1 billion
3M sheds pharma unit for $2.1 billion
November 9, 2006
11:43 pm

3M has agreed to sell-off its global pharmaceuticals business, which makes dermatology, women’s health, cardiology and respiratory treatments, for $2.1 billion.

Abbott to buy Kos for $3.7 billion
Abbott to buy Kos for $3.7 billion
November 7, 2006
11:56 pm

Abbott has agreed to buy specialty firm Kos for $3.7 billion, a move that complements its cardiovascular franchise and boosts its pipeline.

Schering-Plough CEO calls takeover prices ‘breath-taking’
Schering-Plough CEO calls takeover prices ‘breath-taking’
November 7, 2006
11:53 pm

The prices being paid in the recent rash of pharmaceutical acquisition deals are “breath-taking,” Schering-Plough CEO Fred Hassan said in an interview with Marketwatch.com.

Lilly, BMS part of California investigation of anti-psychotics
Lilly, BMS part of California investigation of anti-psychotics
November 7, 2006
11:49 pm

The California attorney general’s office expanded its probe into the marketing of anti-psychotic drugs, serving subpoenas to Eli Lilly and Bristol-Myers Squibb, the companies have said.

Trial results cloud future of Pfizer’s torcetrapib
Trial results cloud future of Pfizer’s torcetrapib
November 7, 2006
11:47 pm

Pfizer confirmed that its leading pipeline candidate torcetrapib raised blood pressure in clinical trial patients more than previously reported.

Lilly, BMS part of California investigation of anti-psychotics
Lilly, BMS part of California investigation of anti-psychotics
November 7, 2006
2:55 am

The California attorney general’s office expanded its probe into the marketing of anti-psychotic drugs, serving subpoenas to Eli Lilly and Bristol-Myers Squibb, the companies have said.

HealthMedia acquires MySelfHelp.com
HealthMedia acquires MySelfHelp.com
November 2, 2006
12:19 am

Behavioral change-focused relationship marketing firm HealthMedia announced today that it has acquired the consumer Web site MySelfHelp.com.

NIH scientists seeking new work in wake of tougher disclosure rules
NIH scientists seeking new work in wake of tougher disclosure rules
October 31, 2006
12:03 am

Nearly 40% of scientists researching diseases and cures at the National Institutes of Health (NIH) are considering new jobs to escape strict ethics rules, a recent survey said.

  • From Our Partners